Question 1

What is Crigler-Najjar syndrome type 1?

Accepted Answer

Crigler-Najjar syndrome type 1 is a severe inherited liver disorder characterized by a complete absence of the enzyme activity required for bilirubin conjugation. This leads to marked unconjugated hyperbilirubinemia and persistent jaundice that typically presents in the neonatal period. The condition results from changes in the UGT1A1 gene and follows an autosomal recessive inheritance pattern. Although precise prevalence estimates are not available, the condition is recognized as an extremely serious and rare metabolic disorder.

Question 2

What are the symptoms of Crigler-Najjar syndrome type 1?

Accepted Answer

The hallmark features of Crigler-Najjar syndrome type 1 include severe unconjugated hyperbilirubinemia and jaundice, which are invariably present in affected individuals. These clinical features are usually evident shortly after birth, prompting early evaluation due to the high bilirubin levels. Not all individuals experience additional symptoms, and severity can vary considerably depending on multiple factors. That while jaundice is universally observed, the clinical spectrum may differ from one person to another.

Question 3

What causes Crigler-Najjar syndrome type 1?

Accepted Answer

Crigler-Najjar syndrome type 1 is caused by pathogenic variants in the UGT1A1 gene, which is responsible for producing the enzyme bilirubin uridine diphosphate glucuronosyltransferase. This enzyme plays a critical role in the process of bilirubin conjugation in the liver. The condition is inherited in an autosomal recessive pattern, meaning that an affected individual has received one altered copy of the gene from each parent. Families are advised to seek genetic counseling to understand recurrence risks and implications for family planning. Associated genes include UGT1A1.

Question 4

How is Crigler-Najjar syndrome type 1 inherited?

Accepted Answer

Crigler-Najjar syndrome type 1 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is Crigler-Najjar syndrome type 1?

Accepted Answer

Crigler-Najjar syndrome type 1 is classified as not well established. The estimated prevalence is approximately Unknown. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is Crigler-Najjar syndrome type 1 diagnosed?

Accepted Answer

Diagnosis of Crigler-Najjar syndrome type 1 is primarily established through molecular genetic testing, which identifies pathogenic variants in the UGT1A1 gene. In addition to genetic testing, clinical evaluation of the characteristic presentation of severe neonatal jaundice and persistently elevated unconjugated bilirubin levels is essential. Since the symptoms can overlap with other bilirubin metabolism disorders, confirmatory molecular analysis is required to distinguish this condition from other causes of hyperbilirubinemia.

Question 7

Are there treatments for Crigler-Najjar syndrome type 1?

Accepted Answer

Currently, management of Crigler-Najjar syndrome type 1 focuses on supportive care and symptom management, as no treatments are specifically approved for this condition. Treatment is tailored to the individual and typically involves a multidisciplinary team to monitor bilirubin levels and manage complications. Given the severity of the enzyme deficiency, ongoing research is exploring potential therapeutic options, and families are encouraged to engage with genetic counseling to explore available supportive strategies. Patients should discuss treatment options with their healthcare team to determine which therapies may be appropriate for their specific situation.

Question 8

Are there clinical trials for Crigler-Najjar syndrome type 1?

Accepted Answer

Yes, there are currently 3 active clinical trials for Crigler-Najjar syndrome type 1 registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 9

What complications can arise from Crigler-Najjar syndrome type 1?

Accepted Answer

Complications from Crigler-Najjar syndrome type 1 can include severe hyperbilirubinemia, which can lead to neurological damage if not managed properly. Because the condition requires careful monitoring of bilirubin levels, there is a risk of complications related to high bilirubin, such as kernicterus. Families should work closely with healthcare providers to monitor and manage these risks.

Question 10

How does Crigler-Najjar syndrome type 1 affect daily life for patients?

Accepted Answer

Living with Crigler-Najjar syndrome type 1 can involve regular medical appointments to monitor bilirubin levels and manage symptoms. Patients may need to follow specific care plans, which can include phototherapy or other supportive treatments. Families often find it helpful to connect with support groups to share experiences and strategies for daily management.

Question 11

What is the prognosis for someone with Crigler-Najjar syndrome type 1?

Accepted Answer

The prognosis for individuals with Crigler-Najjar syndrome type 1 can vary widely based on the severity of their condition and how early they receive care. With appropriate management and monitoring, many individuals can lead fulfilling lives, but they may face challenges related to their health. Ongoing research and improved standards of care continue to enhance outcomes for patients.

Question 12

What specialists should families consult for Crigler-Najjar syndrome type 1?

Accepted Answer

Families dealing with Crigler-Najjar syndrome type 1 should consult with a pediatrician and a specialist in metabolic disorders or genetics. These professionals can help manage the condition and provide guidance on treatment options. Genetic counseling is also recommended to understand the implications for family planning and recurrence risks.

Organ System	Phenotype Count	Example Features
Lab test results	2	High bilirubin levels (unconjugated hyperbilirubinemia), Elevated circulating hepatic transaminase concentration

Kisho

Crigler-Najjar syndrome type 1

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Crigler-Najjar syndrome type 1

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is Crigler-Najjar syndrome type 1?

What are the symptoms of Crigler-Najjar syndrome type 1?

What causes Crigler-Najjar syndrome type 1?

How is Crigler-Najjar syndrome type 1 inherited?

How rare is Crigler-Najjar syndrome type 1?

How is Crigler-Najjar syndrome type 1 diagnosed?

Are there treatments for Crigler-Najjar syndrome type 1?

Are there clinical trials for Crigler-Najjar syndrome type 1?

What complications can arise from Crigler-Najjar syndrome type 1?

How does Crigler-Najjar syndrome type 1 affect daily life for patients?

What is the prognosis for someone with Crigler-Najjar syndrome type 1?

What specialists should families consult for Crigler-Najjar syndrome type 1?

Explore clinical features